Different accumulation of temocapril and enalapril during repeated dosing in elderly patients [2]

British Journal of Clinical Pharmacology

Volumn 59, Issue 4, 2005, Pages 489-490

  Arakawa, Masashi ^a   Ohmori, Masami ^a   Harada, Ken Ichi ^a   Araki, Nobutaka ^a   Saitoh, Tetsuo ^b   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Moka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; TEMOCAPRIL;

ADULT; AGED; AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DIZZINESS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG EXCRETION; ESSENTIAL HYPERTENSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; DRUG ADMINISTRATION SCHEDULE; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; THIAZEPINES;

EID: 17044462178     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02346.x     Document Type: Letter

References (6)

1. Suzuki H, Kawaratani T, Shioya H, Uji Y, Saruta T. Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS-622) in humans. Biopharm Drug Dispos 1993; 14: 41-50.
2. Todd PA, Heel RC. Enalapril. Drugs 1986; 31: 198-248.
3. Oguchi H, Miyasaka M, Koiwai T, Tokunaga S, Hora K, Sato K, Yoshie T, Shioya H, Furuta S. Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency. Clin Pharmacokinet 1993; 24: 421-7.
4. Shioya H, Shimojo M, Kawahara Y. Determination in plasma of angiotensin-converting inhibitor by inhibitor-binding assay. J Chromatogr 1991; 568: 309-14.
5. Ishizuka H, Konno K, Naganuma H, Nishimura K, Kouzuki H, Suzuki H, Stieger B, Meier PJ, Sugiyama Y. Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. J Pharmacol Exp Ther 1998; 287: 37-42.
6. Ishizuka H, Konno K, Naganuma H, Sasahara K, Kawahara Y, Niinuma K, Suzuki H, Sugiyama Y. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai Hyperbilirubinemic Mutant Rats (EHBR). J Pharmacol Exp Ther 1997; 280: 1304-11.